Advertisement
Surgery
Advanced searchSave search
Central Surgical Association| Volume 82, ISSUE 4, P495-503, October 1977

Benign hepatocellular tumors

DOI:https://doi.org/10.5555/uri:pii:0039606077901271
Benign hepatocellular tumors
Previous ArticleSteroids and severe hemorrhagic shock
Next ArticleIntraoperative prediction of symptomatic result of aortofemoral bypass from changes in ankle pressure index
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      This series summarizes all cases diagnosed as benign hepatocellular tumors occurring at the University of Minnesota Hospitals from 1950 to 1976. Excluding hemangiomas, 40 tumors were reviewed and reclassified. Eighteen were diagnosed as focal nodular hyperplasia (FNH), 10 as hepatocellular adenomas (HCS), 11 as bile duct adenomas (BDA), and one as a mesenchymal hamartoma. FNH: The female: male ratio was 8:1, and the mean age was 43 years ±18 (SD). Two patients were symptomatic; of these, one presented with portal hypertension. Treatment consisted of local resection in 12, left hepatectomy in one, and right hepatectomy in two. Eight patients had a history of oral contraceptive or other steroid intake. The tumors occurring after 1964 were larger (p < 0. 05). HCA: The female: male ratio was 4:1, and the mean age was 33 years ±20 (SD). Five tumors were found at necropsy; the other five were symptomatic. Treatment consisted of local resection in one patient, right hepatectomy in two, and left hepatectomy in one. Three patients had a positive history of oral contraceptive intake. There was no statistically significant difference in the size or the incidence of hepatocellular adenomas between the time spans of 1950 to 1963 and 1964 to 1976. BDA: The female: male ratio was 7:4, and the mean age was 57 years ±15 (SD). Only one case was symptomatic and this lesion measured 10 cm. The other BDAs were 1 cm or less in diameter. There is no suggestion that these tumors are associated with use of birth control pills. This series has a lower proportion of symptomatic patients and of patients on oral contraceptives than is suggested by reviewing the literature. From our series we conclude that a causal relationship between use of oral contraceptives, or other steroids, and benign hepatocellular tumors cannot be demonstrated. However, this conclusion does not rule out that oral contraceptives, or other steroids, might have a contributory influence on the initiation of certain of these tumors or on tumor size.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Ameriks J.A.
        • Thompson N.W.
        • Frey C.F.
        • et al.
        Hepatic cell adenomas, spontaneous liver rupture, and oral contraceptives.
        Arch Surg. 1975; 110: 548
        • Andersen P.H.
        • Packer J.T.
        Hepatic adenoma. Observations after estrogen withdrawal.
        Arch Surg. 1976; 111: 898
        • Baum J.K.
        • Holtz F.
        • Bookstein J.J.
        • et al.
        Possible association between benign hepatomas and oral contraceptives.
        Lancet. 1973; 7835: 926
        • Beaconsfield P.
        Liver tumors and steroid hormones.
        Lancet. 1974; 1: 516
        • Benz E.J.
        • Baggenstoss A.H.
        Focal cirrhosis of the liver: Its relation to the so-called hamartoma (adenoma, benign hepatoma).
        Cancer. 1953; 6: 743
        • Bernstein M.S.
        • Hunter R.L.
        • Yachnin S.
        Hepatoma and peliosis hepatis developing in a patient with Fanconi's anemia.
        N Engl J Med. 1971; 284: 1135
        • Committee on Safety of Medicines
        Carcinogenic test of oral contraceptives.
        HMSO, London1972
        • Davis J.B.
        • Schenken J.R.
        • Zimmerman O.
        Massive hemoperitoneum from rupture of benign hepatocellular adenoma.
        Surgery. 1973; 73: 181
        • Edmondson H.A.
        Tumors of the liver and intrahepatic bile ducts.
        Atlas of tumor pathology. 1958; (A.F.I.P. section VII): F 25
        • Edmondson H.A.
        • Henderson B.
        • Benton B.
        Liver-cell adenomas associated with use of oral contraceptives.
        N Engl J Med. 1976; 294: 470
        • Edmondson H.A.
        • Reynolds T.B.
        • Henderson B.
        • et al.
        Regression of liver cell adenomas associated with oral contraceptives.
        Ann Intern Med. 1977; 86: 180
        • Henson S.W.
        • Gray H.K.
        • Dockerty M.B.
        Benign tumors of the liver.
        Surg Gynecol Obstet. 1956; 103: 23
        • Hilliard J.L.
        • Graham D.Y.
        • Spjut H.J.
        Hepatic adenoma: A possible complication of oral contraceptive therapy.
        South Med J. 1976; 69: 683
        • Ishak K.G.
        • Rabin L.
        Benign tumors of the liver.
        Med Clin North Am. 1975; 59: 995
        • Johnson F.L.
        • Feagler J.R.
        • Lerner K.G.
        • et al.
        Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.
        Lancet. 1972; 2: 1273
        • Kalra F.M.
        • Mangla B.C.
        • DePapp E.W.
        Benign hepatic tumors and oral contraceptive pills.
        Am J Med. 1976; 61: 871
        • Kay C.R.
        Oral contraceptives and liver tumors.
        Lancet. 1975; 2: 127
        • Lansing P.B.
        • McQuitty J.T.
        • Bradburn D.M.
        Benign liver tumors: What is their relationship to oral contraceptives.
        Am Surg. 1976; 42: 744
        • Mays E.T.
        • Christopherson W.M.
        • Mahr M.M.
        • et al.
        Hepatic changes in young women ingesting contraceptive steroids.
        JAMA. 1976; 235: 730
        • McAvoy J.M.
        • Thompkins R.K.
        • Longmire W.P.
        Benign hepatic tumors and their association with oral contraceptives.
        Arch Surg. 1976; 111: 761
        • Motsay G.J.
        • Gamble W.G.
        Clinical experience with hepatic adenomas.
        Surg Gynecol Obstet. 1972; 134: 415
        • Phillips M.J.
        • Langer B.
        • Stone R.
        • et al.
        Benign liver cell tumors.
        Cancer. 1973; 32: 463
        • Poulsen H.
        • Winkle K.
        Liver disease with periportal sinusoidal dilatation.
        Digestion. 1973; 8: 441
        • Sorensen T.I.A.
        • Baden H.
        Benign hepatocellular tumors.
        Scand J Gastroenterol. 1975; 10: 113
        • Stauffer J.W.
        • Lapinski M.Q.
        • Honold D.J.
        • et al.
        Focal nodular hyperplasia of the liver and intrahepatic hemorrhage in young women on oral contraceptives.
        Ann Intern Med. 1975; 83: 301
        • Warvi W.N.
        Primary tumors of the liver.
        Surg Gynecol Obstet. 1975; 80: 643

      Article info

      Footnotes

      ☆Presented at the Thirty-fourth Annual Meeting of the Central Surgical Association, Buffalo, N. Y., March 3–5, 1977.

      Identification

      DOI: https://doi.org/10.5555/uri:pii:0039606077901271

      Copyright

      © 1977 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX